List of Tables
Table 1. Global Rare Kidney Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Others
Table 5. Global Rare Kidney Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Rare Kidney Diseases Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Rare Kidney Diseases Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Rare Kidney Diseases Treatment Market Share by Region (2020-2025)
Table 9. Global Rare Kidney Diseases Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Rare Kidney Diseases Treatment Market Share by Region (2026-2031)
Table 11. Rare Kidney Diseases Treatment Market Trends
Table 12. Rare Kidney Diseases Treatment Market Drivers
Table 13. Rare Kidney Diseases Treatment Market Challenges
Table 14. Rare Kidney Diseases Treatment Market Restraints
Table 15. Global Rare Kidney Diseases Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Rare Kidney Diseases Treatment Market Share by Players (2020-2025)
Table 17. Global Top Rare Kidney Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Kidney Diseases Treatment as of 2024)
Table 18. Ranking of Global Top Rare Kidney Diseases Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Rare Kidney Diseases Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Rare Kidney Diseases Treatment, Headquarters and Area Served
Table 21. Global Key Players of Rare Kidney Diseases Treatment, Product and Application
Table 22. Global Key Players of Rare Kidney Diseases Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rare Kidney Diseases Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Rare Kidney Diseases Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Rare Kidney Diseases Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Rare Kidney Diseases Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Rare Kidney Diseases Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Rare Kidney Diseases Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Rare Kidney Diseases Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Rare Kidney Diseases Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Rare Kidney Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Rare Kidney Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Rare Kidney Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Rare Kidney Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Rare Kidney Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Rare Kidney Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Rare Kidney Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Rare Kidney Diseases Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Rare Kidney Diseases Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Rare Kidney Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Rare Kidney Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Rare Kidney Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Rare Kidney Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Rare Kidney Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Rare Kidney Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Aurinia Pharmaceuticals Company Details
Table 48. Aurinia Pharmaceuticals Business Overview
Table 49. Aurinia Pharmaceuticals Rare Kidney Diseases Treatment Product
Table 50. Aurinia Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2020-2025) & (US$ Million)
Table 51. Aurinia Pharmaceuticals Recent Development
Table 52. Sanofi Company Details
Table 53. Sanofi Business Overview
Table 54. Sanofi Rare Kidney Diseases Treatment Product
Table 55. Sanofi Revenue in Rare Kidney Diseases Treatment Business (2020-2025) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Calliditas Therapeutics AB Company Details
Table 58. Calliditas Therapeutics AB Business Overview
Table 59. Calliditas Therapeutics AB Rare Kidney Diseases Treatment Product
Table 60. Calliditas Therapeutics AB Revenue in Rare Kidney Diseases Treatment Business (2020-2025) & (US$ Million)
Table 61. Calliditas Therapeutics AB Recent Development
Table 62. Shire Company Details
Table 63. Shire Business Overview
Table 64. Shire Rare Kidney Diseases Treatment Product
Table 65. Shire Revenue in Rare Kidney Diseases Treatment Business (2020-2025) & (US$ Million)
Table 66. Shire Recent Development
Table 67. GSK Company Details
Table 68. GSK Business Overview
Table 69. GSK Rare Kidney Diseases Treatment Product
Table 70. GSK Revenue in Rare Kidney Diseases Treatment Business (2020-2025) & (US$ Million)
Table 71. GSK Recent Development
Table 72. Amicus Therapeutics Company Details
Table 73. Amicus Therapeutics Business Overview
Table 74. Amicus Therapeutics Rare Kidney Diseases Treatment Product
Table 75. Amicus Therapeutics Revenue in Rare Kidney Diseases Treatment Business (2020-2025) & (US$ Million)
Table 76. Amicus Therapeutics Recent Development
Table 77. Horizon Therapeutics Company Details
Table 78. Horizon Therapeutics Business Overview
Table 79. Horizon Therapeutics Rare Kidney Diseases Treatment Product
Table 80. Horizon Therapeutics Revenue in Rare Kidney Diseases Treatment Business (2020-2025) & (US$ Million)
Table 81. Horizon Therapeutics Recent Development
Table 82. Advicenne Company Details
Table 83. Advicenne Business Overview
Table 84. Advicenne Rare Kidney Diseases Treatment Product
Table 85. Advicenne Revenue in Rare Kidney Diseases Treatment Business (2020-2025) & (US$ Million)
Table 86. Advicenne Recent Development
Table 87. Reata Pharmaceuticals Company Details
Table 88. Reata Pharmaceuticals Business Overview
Table 89. Reata Pharmaceuticals Rare Kidney Diseases Treatment Product
Table 90. Reata Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2020-2025) & (US$ Million)
Table 91. Reata Pharmaceuticals Recent Development
Table 92. Alexion Pharmaceuticals Company Details
Table 93. Alexion Pharmaceuticals Business Overview
Table 94. Alexion Pharmaceuticals Rare Kidney Diseases Treatment Product
Table 95. Alexion Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2020-2025) & (US$ Million)
Table 96. Alexion Pharmaceuticals Recent Development
Table 97. Otsuka Pharmaceutical Company Details
Table 98. Otsuka Pharmaceutical Business Overview
Table 99. Otsuka Pharmaceutical Rare Kidney Diseases Treatment Product
Table 100. Otsuka Pharmaceutical Revenue in Rare Kidney Diseases Treatment Business (2020-2025) & (US$ Million)
Table 101. Otsuka Pharmaceutical Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Rare Kidney Diseases Treatment Picture
Figure 2. Global Rare Kidney Diseases Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Rare Kidney Diseases Treatment Market Share by Type: 2024 VS 2031
Figure 4. Enzyme Replacement Therapy Features
Figure 5. Monoclonal Antibodies Features
Figure 6. Others Features
Figure 7. Global Rare Kidney Diseases Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Rare Kidney Diseases Treatment Market Share by Application: 2024 VS 2031
Figure 9. Atypical Hemolytic Uremic Syndrome Case Studies
Figure 10. Nephropathic Cystinosis Case Studies
Figure 11. Lupus Nephritis Case Studies
Figure 12. Others Case Studies
Figure 13. Rare Kidney Diseases Treatment Report Years Considered
Figure 14. Global Rare Kidney Diseases Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Rare Kidney Diseases Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Rare Kidney Diseases Treatment Market Share by Region: 2024 VS 2031
Figure 17. Global Rare Kidney Diseases Treatment Market Share by Players in 2024
Figure 18. Global Top Rare Kidney Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Kidney Diseases Treatment as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Rare Kidney Diseases Treatment Revenue in 2024
Figure 20. North America Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Rare Kidney Diseases Treatment Market Share by Country (2020-2031)
Figure 22. United States Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Rare Kidney Diseases Treatment Market Share by Country (2020-2031)
Figure 26. Germany Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Rare Kidney Diseases Treatment Market Share by Region (2020-2031)
Figure 34. China Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Rare Kidney Diseases Treatment Market Share by Country (2020-2031)
Figure 42. Mexico Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Rare Kidney Diseases Treatment Market Share by Country (2020-2031)
Figure 46. Turkey Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Rare Kidney Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Aurinia Pharmaceuticals Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2020-2025)
Figure 51. Calliditas Therapeutics AB Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2020-2025)
Figure 52. Shire Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2020-2025)
Figure 53. GSK Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2020-2025)
Figure 54. Amicus Therapeutics Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2020-2025)
Figure 55. Horizon Therapeutics Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2020-2025)
Figure 56. Advicenne Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2020-2025)
Figure 57. Reata Pharmaceuticals Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2020-2025)
Figure 58. Alexion Pharmaceuticals Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2020-2025)
Figure 59. Otsuka Pharmaceutical Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
